Congress Start Date
Congress End Date
Abstract Last
Submission Date
Dear Colleagues,
It is with immense pleasure that the American Association for the Study of Liver Diseases (AASLD) and the Turkish Association for the Study of the Liver (TASL) announce our sixth joint AASLD-TASL Hepatology CONNECT conference. This annual program reflects the two societies’ shared commitment to delivering the highest quality of care to our patients, advancing knowledge through research and collaboration and investing in the future by training the best qualified hepatology workforce in both countries.
Built on our prior success, the upcoming program is designed to deliver practical updates, including the highly informative The Liver Meeting (TLM) Debriefs in major areas of hepatology. One of the strengths of the program is our emphasis on interactive case-based discussions that draw on expertise of both American and Turkish faculty. As with prior years, we offer attendees of our AASLD-TASL Hepatology CONNECT program from Türkiye and the surrounding region to also register, at no additional cost, for TLM2024 on-line.
This year’s comprehensive program will cover steatotic liver disease and obesity, viral hepatitis, alcohol-associated liver disease, cirrhosis and liver transplantation and liver cancer. The opportunity to interact with the AASLD faculty and with local and regional experts in the science and practice of hepatology has made our CONNECT program a must-attend combination of events for the audience from Türkiye and the surrounding region.
We would be grateful to partner with organizations and sponsors that share our vision of collaboration and advancement. Your support of this meeting is vital so that we can provide attendees with the highest quality meeting experience. It is particularly important under the current international and economic circumstances that challenge scientific and educational programs like this. AASLD and TASL stand together that it is our shared mission to provide the best care to our patients with liver disease and alleviate their suffering no matter the difficulty. As you may have experienced in our prior programs, our partnership is mutually beneficial. There will be opportunities for satellite symposia, exhibit and product theater space, and in-person interactions with hundreds of attendees from Türkiye and all over the region. In this collaborative program, we will again offer US attendees of TLM 2024 to register for the CONNECT program at a nominal cost. By attending both meetings, participants will learn the science and practice of liver disease in a uniquely tangible fashion.
On behalf of AASLD and TASL, we would like to thank you in advance for your participation. Your engagement and support directly propel us to carry out our mission to prevent and ultimately cure liver disease in Türkiye and the world over.
Sincerely,
Congress Start Date
Congress End Date
Abstract Last
Submission Date